Henrique Couto Teixeira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Henrique Couto Teixeira has a total of 311 co-authors. Here are the top co-authors by number of shared publications:
- Caio César Souza Alves
Universidade Federal dos Vales do Jequitinhonha e Mucuri, Diamantina, Brazil
17 shared publications Ana Paula Ferreira
Department of Parasitology, Microbiology and Immunology, Institute of Biological Sciences, Federal University of Juiz De Fora, 36036-900, Juiz de Fora, Minas Gerais, Brazil
14 shared publications- Ana Paula Ferreira
Department of Parasitology, Microbiology and Immunology, Institute of Biological Sciences, Federal University of Juiz de Fora, Juiz de Fora, Brazil
7 shared publications Clarice Abramo
Department Parasitology, Microbiology and Immunology, Institute of Biological Sciences, Federal University of Juiz de Fora, Minas Gerais, Brazil
5 shared publicationsMichele F. Rodrigues
Department of Parasitology, Microbiology and Immunology, Biological Sciences Institute, Federal University of Juiz de Fora, Juiz de Fora, MG, Brazil
5 shared publications- Ulrich Steinhoff
Institute for Medical Microbiology and Hygiene, Philipps University of Marburg, Marburg, Germany
5 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 52, 1-9
Impacto das proteínas de checkpoint imunológico (CTLA-4, PD-1, LAG-3, CD39/CD73) na modulação da resposta imune na hanseníase paucibacilar e multibacilar: Revisão de literatura
Introdução: A hanseníase é uma doença infecciosa crônica negligenciada que permanece como um grave problema de saúde pública no Brasil. A doença é causada pelo Mycobacterium leprae e pode progredir para formas disseminadas ligadas a falhas da resposta imune celular, caracterizadas por um perfil de exaustão linfocitária e imunossupressão. Objetivo: Visando aprofundar a compreensão dos mecanismos imunológicos inibitórios que levam à incapacidade do hospedeiro de controlar a doença, analisamos criticamente os estudos que avaliaram a expressão de checkpoints imunológicos, ou biomarcadores de exaustão imunológica, em células de pacientes com hanseníase paucibacilar (PB) e multibacilar (MB). Material e Métodos: Nesta revisão de literatura, a busca estruturada combinou os biomarcadores de exaustão imunológica (CTLA-4, PD-1, LAG-3, CD39) e hanseníase nas bases de dados PubMed, Scopus, Embase, Web of Science e LILACS. Após a triagem, 19 artigos originais focados em pesquisa clínica e na expressão dos biomarcadores foram incluídos na síntese descritiva. Resultados: Pacientes com as formas MB apresentaram superexpressão de proteínas de checkpoint imunológico CTLA-4 e PD-1 em linfócitos T efetores e células T reguladoras (Tregs). Essas vias, em conjunto com a expansão de Tregs e células B reguladoras (Bregs), ambas produtoras de citocinas supressoras, sustentam a hiporresponsividade dos pacientes MB. Uma maior expressão do biomarcador LAG-3 em pacientes MB e o comprometimento parcial da via purinérgica (CD39/CD73) também foram evidenciados, contribuindo para o desequilíbrio imunológico. O bloqueio de checkpoints imunológicos, em especial o PD-1, se mostrou capaz de restaurar a função imune efetora. Conclusão: A exaustão linfocitária mediada pela expressão de múltiplas proteínas de checkpoint imunológico, principalmente CTLA-4, PD-1 e LAG-3, se mostra como um eixo significativo na imunopatogênese da hanseníase. A compreensão dos mecanismos envolvidos pode favorecer a identificação de novos biomarcadores diagnósticos e o desenvolvimento de estratégias terapêuticas imunomoduladoras com potencial para otimizar o controle da hanseníase.
- 16 September 2026
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 52, 1-9
Open AccessImpacto das proteínas de checkpoint imunológico (CTLA-4, PD-1, LAG-3, CD39/CD73) na modulação da resposta imune na hanseníase paucibacilar e multibacilar: Revisão de literatura
Introdução: A hanseníase é uma doença infecciosa crônica negligenciada que permanece como um grave problema de saúde pública no Brasil. A doença é causada pelo Mycobacterium leprae e pode progredir para formas disseminadas ligadas a falhas da resposta imune celular, caracterizadas por um perfil de exaustão linfocitária e imunossupressão. Objetivo: Visando aprofundar a compreensão dos mecanismos imunológicos inibitórios que levam à incapacidade do hospedeiro de controlar a doença, analisamos criticamente os estudos que avaliaram a expressão de checkpoints imunológicos, ou biomarcadores de exaustão imunológica, em células de pacientes com hanseníase paucibacilar (PB) e multibacilar (MB). Material e Métodos: Nesta revisão de literatura, a busca estruturada combinou os biomarcadores de exaustão imunológica (CTLA-4, PD-1, LAG-3, CD39) e hanseníase nas bases de dados PubMed, Scopus, Embase, Web of Science e LILACS. Após a triagem, 19 artigos originais focados em pesquisa clínica e na expressão dos biomarcadores foram incluídos na síntese descritiva. Resultados: Pacientes com as formas MB apresentaram superexpressão de proteínas de checkpoint imunológico CTLA-4 e PD-1 em linfócitos T efetores e células T reguladoras (Tregs). Essas vias, em conjunto com a expansão de Tregs e células B reguladoras (Bregs), ambas produtoras de citocinas supressoras, sustentam a hiporresponsividade dos pacientes MB. Uma maior expressão do biomarcador LAG-3 em pacientes MB e o comprometimento parcial da via purinérgica (CD39/CD73) também foram evidenciados, contribuindo para o desequilíbrio imunológico. O bloqueio de checkpoints imunológicos, em especial o PD-1, se mostrou capaz de restaurar a função imune efetora. Conclusão: A exaustão linfocitária mediada pela expressão de múltiplas proteínas de checkpoint imunológico, principalmente CTLA-4, PD-1 e LAG-3, se mostra como um eixo significativo na imunopatogênese da hanseníase. A compreensão dos mecanismos envolvidos pode favorecer a identificação de novos biomarcadores diagnósticos e o desenvolvimento de estratégias terapêuticas imunomoduladoras com potencial para otimizar o controle da hanseníase.
- Open Access
Refinement of the rKLi8.3-Based Serodiagnostic ELISA Allows Detection of Canine Leishmaniosis in Dogs with Low Antibody Titers
The diagnosis of canine leishmaniasis (CanL) still represents a challenge due to the variable clinical manifestations and the large number of asymptomatic dogs. Serological tests are most commonly used to detect infected animals, revealing anti-Leishmania antibodies, mainly of the IgG isotype. Recently, a new diagnostic antigen, rKLi8.3, containing 8.3 kinesin tandem repeats (TR) from a Leishmania infantum strain from Sudan, has been shown to provide excellent specificity and sensitivity for the detection of Leishmania-infected humans and dogs. However, asymptomatic animals with very low antibody titers are often difficult to detect by serodiagnosis. Thus, we wondered whether the addition of an anti-IgG-enhancing step in the protein A/G-based rKLi8.3-ELISA will improve the diagnostic performance without decreasing the specificity. For this, parasitologically confirmed CanL cases with low or high clinical scores, uninfected healthy controls and dogs with other infections were tested by rKLi8.3-ELISA as well as two different immunochromatographic rapid tests, rKLi8.3-lateral flow test (LFT) and Dual Path Platform (DPP®) based on the rK28 antigen. Our results show that the diagnostic accuracies of the rKLi8.3-ELISA and LFT were similar to that of DPP, missing several asymptomatic animals. However, the addition of a secondary, amplifying anti-dog IgG antibody in the protein A/G-based rKLi8.3-ELISA enabled the detection of nearly all asymptomatic dogs without compromising its specificity.
Open AccessRefinement of the rKLi8.3-Based Serodiagnostic ELISA Allows Detection of Canine Leishmaniosis in Dogs with Low Antibody Titers
The diagnosis of canine leishmaniasis (CanL) still represents a challenge due to the variable clinical manifestations and the large number of asymptomatic dogs. Serological tests are most commonly used to detect infected animals, revealing anti-Leishmania antibodies, mainly of the IgG isotype. Recently, a new diagnostic antigen, rKLi8.3, containing 8.3 kinesin tandem repeats (TR) from a Leishmania infantum strain from Sudan, has been shown to provide excellent specificity and sensitivity for the detection of Leishmania-infected humans and dogs. However, asymptomatic animals with very low antibody titers are often difficult to detect by serodiagnosis. Thus, we wondered whether the addition of an anti-IgG-enhancing step in the protein A/G-based rKLi8.3-ELISA will improve the diagnostic performance without decreasing the specificity. For this, parasitologically confirmed CanL cases with low or high clinical scores, uninfected healthy controls and dogs with other infections were tested by rKLi8.3-ELISA as well as two different immunochromatographic rapid tests, rKLi8.3-lateral flow test (LFT) and Dual Path Platform (DPP®) based on the rK28 antigen. Our results show that the diagnostic accuracies of the rKLi8.3-ELISA and LFT were similar to that of DPP, missing several asymptomatic animals. However, the addition of a secondary, amplifying anti-dog IgG antibody in the protein A/G-based rKLi8.3-ELISA enabled the detection of nearly all asymptomatic dogs without compromising its specificity.
- Open Access
Comparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil
Control of canine infections with Leishmania infantum (L. infantum), a major zoonotic disease in Brazil and southern Europe, is becoming increasingly important due to its close proximity to humans, the increasing import of dogs from endemic regions and the impact of climate change on vector spreading. Simple, rapid and reliable diagnostic tests are therefore needed to detect infected dogs. Here, we re-evaluated different serological methods for the diagnosis of canine leishmaniosis (CanL) in Croatia and Brazil. The diagnostic performance of the indirect fluorescent antibody test (IFAT) and the VetLine® Leishmania ELISA (GSD Frankfurt, Germany) was compared with three rKLi8.3-based diagnostic test systems, the rKLi8.3 ELISA (GSD Frankfurt, Germany), the INgezim® Leishma CROM (GSD Madrid, Spain) lateral flow test (LFT) and the VetBlot® Leishmania LineBlot (GSD Frankfurt, Germany). CanL symptomatic dogs were efficiently diagnosed by all tests, except the VetLine® Leishmania ELISA, which is based on whole Leishmania antigens. The advantage of rKLi8.3 was also observed in oligo- and asymptomatic dogs from Brazil and Croatia, although with reduced diagnostic efficiency compared to symptomatic dogs. Similar to IFAT and rKLi8.3 ELISA, the LFT did not cross-react with other common canine pathogens; it showed very high specificity for healthy dogs from endemic regions in both countries and did not react with healthy, vaccinated dogs in Brazil. In conclusion, serodiagnostic tests based on the rKLi8.3 antigens are superior to whole parasite antigens, and the LFT has the advantage of providing a laboratory-independent, rapid and specific diagnosis of CanL.
Open AccessComparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil
Control of canine infections with Leishmania infantum (L. infantum), a major zoonotic disease in Brazil and southern Europe, is becoming increasingly important due to its close proximity to humans, the increasing import of dogs from endemic regions and the impact of climate change on vector spreading. Simple, rapid and reliable diagnostic tests are therefore needed to detect infected dogs. Here, we re-evaluated different serological methods for the diagnosis of canine leishmaniosis (CanL) in Croatia and Brazil. The diagnostic performance of the indirect fluorescent antibody test (IFAT) and the VetLine® Leishmania ELISA (GSD Frankfurt, Germany) was compared with three rKLi8.3-based diagnostic test systems, the rKLi8.3 ELISA (GSD Frankfurt, Germany), the INgezim® Leishma CROM (GSD Madrid, Spain) lateral flow test (LFT) and the VetBlot® Leishmania LineBlot (GSD Frankfurt, Germany). CanL symptomatic dogs were efficiently diagnosed by all tests, except the VetLine® Leishmania ELISA, which is based on whole Leishmania antigens. The advantage of rKLi8.3 was also observed in oligo- and asymptomatic dogs from Brazil and Croatia, although with reduced diagnostic efficiency compared to symptomatic dogs. Similar to IFAT and rKLi8.3 ELISA, the LFT did not cross-react with other common canine pathogens; it showed very high specificity for healthy dogs from endemic regions in both countries and did not react with healthy, vaccinated dogs in Brazil. In conclusion, serodiagnostic tests based on the rKLi8.3 antigens are superior to whole parasite antigens, and the LFT has the advantage of providing a laboratory-independent, rapid and specific diagnosis of CanL.
- Open Access
- 24 January 2024
- Published by MDPI AG in Preprints.org
Refinement of the rKLi8.3 Based Serodiagnostic Elisa Allows Detection of Canine Visceral Leishmaniasis in Dogs with Low Antibody Titers
Diagnosis of canine leishmaniosis (CanL) still represents a major challenge due to the variable clinical manifestations and the large number of asymptomatic dogs. Serological tests are most commonly used to detect infected animals, revealing anti-Leishmania antibodies, mainly of IgG isotype. Recently, a new diagnostic antigen, rKLi8.3, containing 8.3 kinesin tandem repeats (TR) from an Leishmania infantum strain from Sudan has been shown to provide excellent specificity and sensitivity to Leishmania infected humans and dogs. However, asymptomatic animals with very low antibody titers are often difficult to detect by serodiagnosis. Thus, we wondered whether addition of an anti-IgG-enhancing step in the protein A/G-based rKLi8.3-ELISA will improve the diagnostic performance without decreasing the specificity. For this, parasitologically confirmed CanL cases with low or high clinical score, uninfected healthy controls and dogs with other infections were tested by rKLi8.3-ELISA as well as two different immunochromatographic rapid tests, rKLi8.3-lateral flow test (LFT) and Dual Path Platform (DPP®) based on the rK28 antigen. Our results show that the diagnostic accuracy of the rKLi8.3-ELISA and LFT was similar to that of DPP, missing several asymptomatic animals. However, addition of a secondary, amplifying anti-dog IgG antibody in the protein A/G-based rKLi8.3-ELISA enabled the detection of nearly all asymptomatic dogs without affecting its specificity.
- 24 January 2024
- Published by MDPI AG in Preprints.org
Open AccessRefinement of the rKLi8.3 Based Serodiagnostic Elisa Allows Detection of Canine Visceral Leishmaniasis in Dogs with Low Antibody Titers
Diagnosis of canine leishmaniosis (CanL) still represents a major challenge due to the variable clinical manifestations and the large number of asymptomatic dogs. Serological tests are most commonly used to detect infected animals, revealing anti-Leishmania antibodies, mainly of IgG isotype. Recently, a new diagnostic antigen, rKLi8.3, containing 8.3 kinesin tandem repeats (TR) from an Leishmania infantum strain from Sudan has been shown to provide excellent specificity and sensitivity to Leishmania infected humans and dogs. However, asymptomatic animals with very low antibody titers are often difficult to detect by serodiagnosis. Thus, we wondered whether addition of an anti-IgG-enhancing step in the protein A/G-based rKLi8.3-ELISA will improve the diagnostic performance without decreasing the specificity. For this, parasitologically confirmed CanL cases with low or high clinical score, uninfected healthy controls and dogs with other infections were tested by rKLi8.3-ELISA as well as two different immunochromatographic rapid tests, rKLi8.3-lateral flow test (LFT) and Dual Path Platform (DPP®) based on the rK28 antigen. Our results show that the diagnostic accuracy of the rKLi8.3-ELISA and LFT was similar to that of DPP, missing several asymptomatic animals. However, addition of a secondary, amplifying anti-dog IgG antibody in the protein A/G-based rKLi8.3-ELISA enabled the detection of nearly all asymptomatic dogs without affecting its specificity.
- Open Access
- 4 December 2023
- Published by MDPI AG in Preprints.org
Comparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test-Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil
Control of canine infections with Leishmania infantum (L. infantum), a major zoonotic disease in Brazil and southern Europe is becoming increasingly important due to their close proximity to humans, the increasing import of dogs from endemic regions and impact of climate change on vector spreading. Simple, rapid and reliable diagnostic tests are therefore needed to detect infected dogs. Here, we re-evaluated different serological methods for the diagnosis of canine leishmaniosis (CanL) in Croatia and Brazil. The diagnostic performance of the indirect fluorescent antibody test (IFAT) and the VetLine® Leishmania ELISA was compared with three rKLi8.3 based diagnostic test systems, the rKLi8.3 ELISA, the INgezim® Leishma CROM lateral flow test (LFT) and the VetBlot® Leishmania LineBlot. CanL symptomatic dogs were efficiently diagnosed by all tests, except the VetLine® Leishmania ELISA, which is based on whole Leishmania antigens. The advantage of rKLi8.3 was also observed in oligo-and asymptomatic dogs from Brazil and Croatia, although with reduced diagnostic efficiency compared to symptomatic dogs. Similar to IFAT and rKLi8.3 ELISA, the LFT did not cross-react with other common canine pathogens, showed a very high specificity for healthy dogs from endemic regions of both countries and did not react with healthy, vaccinated dogs in Brazil. In conclusion, sero-diagnostic tests based on the rKLi8.3 antigens are superior to whole parasite antigens and the LFT has the advantage of providing a laboratory independent, rapid and specific diagnosis of CanL.
- 4 December 2023
- Published by MDPI AG in Preprints.org
Open AccessComparative Study of a Novel Lateral Flow Rapid Test with Conventional Serological Test-Systems for the Diagnosis of Canine Leishmaniosis in Croatia and Brazil
Control of canine infections with Leishmania infantum (L. infantum), a major zoonotic disease in Brazil and southern Europe is becoming increasingly important due to their close proximity to humans, the increasing import of dogs from endemic regions and impact of climate change on vector spreading. Simple, rapid and reliable diagnostic tests are therefore needed to detect infected dogs. Here, we re-evaluated different serological methods for the diagnosis of canine leishmaniosis (CanL) in Croatia and Brazil. The diagnostic performance of the indirect fluorescent antibody test (IFAT) and the VetLine® Leishmania ELISA was compared with three rKLi8.3 based diagnostic test systems, the rKLi8.3 ELISA, the INgezim® Leishma CROM lateral flow test (LFT) and the VetBlot® Leishmania LineBlot. CanL symptomatic dogs were efficiently diagnosed by all tests, except the VetLine® Leishmania ELISA, which is based on whole Leishmania antigens. The advantage of rKLi8.3 was also observed in oligo-and asymptomatic dogs from Brazil and Croatia, although with reduced diagnostic efficiency compared to symptomatic dogs. Similar to IFAT and rKLi8.3 ELISA, the LFT did not cross-react with other common canine pathogens, showed a very high specificity for healthy dogs from endemic regions of both countries and did not react with healthy, vaccinated dogs in Brazil. In conclusion, sero-diagnostic tests based on the rKLi8.3 antigens are superior to whole parasite antigens and the LFT has the advantage of providing a laboratory independent, rapid and specific diagnosis of CanL.
- Open Access
- 10 August 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Serum IgA Antibodies Specific to M. leprae Antigens as Biomarkers for Leprosy Detection and Household Contact Tracking
Leprosy remains endemic in several developing countries, such as India and Brazil, in part due to delayed diagnosis that facilitates ongoing transmission. Although immunoglobulins against several Mycobacterium leprae antigens have been indicated for the early diagnosis, and IgA participates in the early stages of leprosy and in subclinical infection, relatively little research has examined anti-M. leprae IgA responses. Here, we investigated serum IgA reactivity against NDO-HSA, LID-1 and NDO-LID, in paucibacillary (PB) and multibacillary (MB) patients and their household contacts, using enzyme-linked immunosorbent assay (ELISA). Diagnostic accuracy of each ELISA was evaluated by receiver operating characteristic (ROC) curve analysis. Our data reveal elevated IgA serum levels against the three M. leprae specific antigens in MB patients, whereas IgA reactivity in PB patients was increased only to NDO-HSA. Further, MB and PB household contacts displayed higher IgA reactivity to NDO-HSA than non-endemic controls. Our data suggest measurement of serum IgA against NDO-HSA as an additional tool in the diagnosis and classification of the disease, with potential utility for household contact follow-up.
- 10 August 2021
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 8
Open AccessSerum IgA Antibodies Specific to M. leprae Antigens as Biomarkers for Leprosy Detection and Household Contact Tracking
Leprosy remains endemic in several developing countries, such as India and Brazil, in part due to delayed diagnosis that facilitates ongoing transmission. Although immunoglobulins against several Mycobacterium leprae antigens have been indicated for the early diagnosis, and IgA participates in the early stages of leprosy and in subclinical infection, relatively little research has examined anti-M. leprae IgA responses. Here, we investigated serum IgA reactivity against NDO-HSA, LID-1 and NDO-LID, in paucibacillary (PB) and multibacillary (MB) patients and their household contacts, using enzyme-linked immunosorbent assay (ELISA). Diagnostic accuracy of each ELISA was evaluated by receiver operating characteristic (ROC) curve analysis. Our data reveal elevated IgA serum levels against the three M. leprae specific antigens in MB patients, whereas IgA reactivity in PB patients was increased only to NDO-HSA. Further, MB and PB household contacts displayed higher IgA reactivity to NDO-HSA than non-endemic controls. Our data suggest measurement of serum IgA against NDO-HSA as an additional tool in the diagnosis and classification of the disease, with potential utility for household contact follow-up.
- Open Access
- 14 October 2020
- Published by Akademiai Kiado Zrt. in European Journal of Microbiology and Immunology
- Vol. 10 (3) , 165-171
Performance of recombinant proteins in diagnosis and differentiation of canine visceral leishmaniasis infected and vaccinated dogs
Control of canine visceral leishmaniasis (CVL), a major zoonotic disease in Brazil and many other tropical and subtropical countries, remains difficult as an accurate and reliable diagnosis is still missing. In endemic regions, infected dogs are the main parasitic reservoir host of human Visceral leishmaniasis (VL) infection. Vaccination of dogs against Leishmania infection constitutes an important strategy to prevent or to better control CVL, thus, a serological test that can discriminate between antibodies induced by immunization versus infection is highly desirable in order to improve and simplify diagnosis. Here, four recombinant proteins were evaluated for their ability to detect and differentiate between dogs that are infected with Leishmania or have been immunized with the anti-Leishmania vaccine Leish-Tec®. Receiver operating characteristic (ROC) curve analysis of the four Leishmania-specific IgG ELISA revealed superior performance of rK28, followed by rKLO8, rK39 and rLb6H. The rK28-based ELISA revealed not only the best accuracy against CVL, but also the lowest cross-reactivity with sera from Leish-Tec® immunized dogs. Our data show that the rK28-based ELISA is highly suitable for CVL screening as it shows high sensitivity with simultaneous low cross-reactivity. Further, the high specificity of the rKLO8 indicates its suitability for the confirmation of CVL diagnosis.
- 14 October 2020
- Published by Akademiai Kiado Zrt. in European Journal of Microbiology and Immunology
- Vol. 10 (3) , 165-171
Open AccessPerformance of recombinant proteins in diagnosis and differentiation of canine visceral leishmaniasis infected and vaccinated dogs
Control of canine visceral leishmaniasis (CVL), a major zoonotic disease in Brazil and many other tropical and subtropical countries, remains difficult as an accurate and reliable diagnosis is still missing. In endemic regions, infected dogs are the main parasitic reservoir host of human Visceral leishmaniasis (VL) infection. Vaccination of dogs against Leishmania infection constitutes an important strategy to prevent or to better control CVL, thus, a serological test that can discriminate between antibodies induced by immunization versus infection is highly desirable in order to improve and simplify diagnosis. Here, four recombinant proteins were evaluated for their ability to detect and differentiate between dogs that are infected with Leishmania or have been immunized with the anti-Leishmania vaccine Leish-Tec®. Receiver operating characteristic (ROC) curve analysis of the four Leishmania-specific IgG ELISA revealed superior performance of rK28, followed by rKLO8, rK39 and rLb6H. The rK28-based ELISA revealed not only the best accuracy against CVL, but also the lowest cross-reactivity with sera from Leish-Tec® immunized dogs. Our data show that the rK28-based ELISA is highly suitable for CVL screening as it shows high sensitivity with simultaneous low cross-reactivity. Further, the high specificity of the rKLO8 indicates its suitability for the confirmation of CVL diagnosis.
- Open Access
- 28 November 2019
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 45 (3) , 325-333
Proteínas de checkpoint imunológico como novo alvo da imunoterapia contra o câncer: revisão da literatura
Uma nova era no tratamento do câncer está surgindo com o uso de anticorpos capazes de inibir pontos de bloqueio do sistema imunológico, chamados de “inibidores de checkpoint”. Um novo conceito de “balas mágicas”, que no início do século passado foram imaginadas por Paul Ehrlich como capazes de atuar diretamente na destruição de alvos tumorais, é representado agora por anticorpos direcionadas contra moléculas que bloqueiam a atividade antitumoral do sistema imunológico, como o antígeno de linfócitos T citotóxicos-4 (CTLA-4) e a proteína-1 de morte celular programada (PD-1). Essas novas imunoterapias vêm revolucionando a forma de tratar diferentes tipos de câncer. Nesta revisão selecionamos estudos, sobre CTLA-4 e PD-1, seus ligantes em células apresentadoras de antígenos, assim como destacamos a importância da descoberta de antígenos tumorais e o papel do sistema imunológico na imunovigilância tumoral. Nesse estudo são discutidos aspectos relacionados aos efeitos de imunoterapias baseadas no uso de anticorpos monoclonais anti-CTLA-4 e anti-PD-1/ PD-L1, como o risco de serem estimuladas respostas direcionadas a tecidos saudáveis e outros efeitos adversos, bem como o uso de terapias combinadas que podem contribuir para melhorar a eficiência do tratamento do câncer.
- 28 November 2019
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 45 (3) , 325-333
Open AccessProteínas de checkpoint imunológico como novo alvo da imunoterapia contra o câncer: revisão da literatura
Uma nova era no tratamento do câncer está surgindo com o uso de anticorpos capazes de inibir pontos de bloqueio do sistema imunológico, chamados de “inibidores de checkpoint”. Um novo conceito de “balas mágicas”, que no início do século passado foram imaginadas por Paul Ehrlich como capazes de atuar diretamente na destruição de alvos tumorais, é representado agora por anticorpos direcionadas contra moléculas que bloqueiam a atividade antitumoral do sistema imunológico, como o antígeno de linfócitos T citotóxicos-4 (CTLA-4) e a proteína-1 de morte celular programada (PD-1). Essas novas imunoterapias vêm revolucionando a forma de tratar diferentes tipos de câncer. Nesta revisão selecionamos estudos, sobre CTLA-4 e PD-1, seus ligantes em células apresentadoras de antígenos, assim como destacamos a importância da descoberta de antígenos tumorais e o papel do sistema imunológico na imunovigilância tumoral. Nesse estudo são discutidos aspectos relacionados aos efeitos de imunoterapias baseadas no uso de anticorpos monoclonais anti-CTLA-4 e anti-PD-1/ PD-L1, como o risco de serem estimuladas respostas direcionadas a tecidos saudáveis e outros efeitos adversos, bem como o uso de terapias combinadas que podem contribuir para melhorar a eficiência do tratamento do câncer.
- Open Access
- 21 June 2019
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 44 (3) , 369-378
Efeitos contrastantes da vitamina D sobre a resposta imune inata e adquirida e seu impacto na recuperação da tuberculose
A vitamina D é um hormônio essencial para o organismo, podendo ser obtida da dieta ou, principalmente, gerada pela pele após exposição à luz solar ultravioleta B. Na sua forma ativa (1,25(OH)2D) ela controla a absorção de cálcio e fósforo do intestino para a corrente sanguínea e participa de diversos processos celulares e fisiológicos. A ligação da 1,25(OH)2D ao receptor da vitamina D (VDR) presente em diversas células, como as células do sistema imunológico, induz a transcrição de genes que podem, por exemplo, modular a resposta imune inata e adquirida. A deficiência de vitamina D ou do VDR é associada a problemas de saúde como desordens esqueléticas, hipertensão, doenças cardiovasculares, diabetes mellitus, dislipidemias, doenças autoimunes e doenças infecciosas. Neste sentido, a suplementação com vitamina D tem sido proposta como uma possível medida preventiva, podendo ser aplicada em muitas patologias, em especial na tuberculose. Principal causa de morte por um único agente infeccioso, a tuberculose é responsável por cerca de 1,3 milhões de óbitos por ano no mundo. Publicações recentes apontam efeitos diversos da vitamina D na resposta imune inata e adquirida. A 1,25(OH)2D3 na presença do interferon (IFN)-γ é capaz de aumentar a atividade bactericida do macrófago contra o M. tuberculosis, aumentando a produção de peptídios antimicrobianos e estimulando a autofagia, favorecendo assim a lise de bacilos localizados em fagossomos. Por outro lado, a vitamina D em linfócitos T mostra efeito tolerogênico que favorece o controle de respostas inflamatórias excessivas. Neste trabalho de revisão são apresentados estudos recentes envolvendo efeitos da vitamina D na resposta imune inata e adquirida. Além disso, considerações sobre deficiência de vitamina D e maior risco de contrair tuberculose, e efeitos contrastantes da suplementação com vitamina D na prevenção e tratamento da TB, são discutidos.
- 21 June 2019
- Published by Universidade Federal de Juiz de Fora in HU Revista
- Vol. 44 (3) , 369-378
Open AccessEfeitos contrastantes da vitamina D sobre a resposta imune inata e adquirida e seu impacto na recuperação da tuberculose
A vitamina D é um hormônio essencial para o organismo, podendo ser obtida da dieta ou, principalmente, gerada pela pele após exposição à luz solar ultravioleta B. Na sua forma ativa (1,25(OH)2D) ela controla a absorção de cálcio e fósforo do intestino para a corrente sanguínea e participa de diversos processos celulares e fisiológicos. A ligação da 1,25(OH)2D ao receptor da vitamina D (VDR) presente em diversas células, como as células do sistema imunológico, induz a transcrição de genes que podem, por exemplo, modular a resposta imune inata e adquirida. A deficiência de vitamina D ou do VDR é associada a problemas de saúde como desordens esqueléticas, hipertensão, doenças cardiovasculares, diabetes mellitus, dislipidemias, doenças autoimunes e doenças infecciosas. Neste sentido, a suplementação com vitamina D tem sido proposta como uma possível medida preventiva, podendo ser aplicada em muitas patologias, em especial na tuberculose. Principal causa de morte por um único agente infeccioso, a tuberculose é responsável por cerca de 1,3 milhões de óbitos por ano no mundo. Publicações recentes apontam efeitos diversos da vitamina D na resposta imune inata e adquirida. A 1,25(OH)2D3 na presença do interferon (IFN)-γ é capaz de aumentar a atividade bactericida do macrófago contra o M. tuberculosis, aumentando a produção de peptídios antimicrobianos e estimulando a autofagia, favorecendo assim a lise de bacilos localizados em fagossomos. Por outro lado, a vitamina D em linfócitos T mostra efeito tolerogênico que favorece o controle de respostas inflamatórias excessivas. Neste trabalho de revisão são apresentados estudos recentes envolvendo efeitos da vitamina D na resposta imune inata e adquirida. Além disso, considerações sobre deficiência de vitamina D e maior risco de contrair tuberculose, e efeitos contrastantes da suplementação com vitamina D na prevenção e tratamento da TB, são discutidos.
- Open Access
- 6 July 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 146 (14) , 1750-1755
Assessing epidemiology of leprosy and socio-economic distribution of cases
Leprosy still represents a serious health problem in a number of countries, including Brazil. Although leprosy has been associated with poverty for a long time, it is still difficult to accurately define this relationship. Here, we evaluated in an endemic municipality the progress from 1995 to 2015 of epidemiological indicators to establish if there were any strong associations between social indicators and the occurrence of leprosy. An ecological study was conducted using the SINAN database (Brazilian leprosy-national notifiable diseases information system) in combination with georeferencing of leprosy cases. The georeferencing used the ArcGis programme and occurrence of cases was evaluated in relation to the Health Vulnerability Index (HVI), an indicator that categorises socio-economic and sanitation factors. The data identified a marked decrease in the overall prevalence of leprosy, a reduction in the new case-detection rate and a reduction in the number of cases with grade 2 disabilities (albeit with transient peaks in 2007 and 2015). Logistic regression analysis showed association of detection rates with elevated HVI. Thus, while the epidemiological indicators point to the elimination of leprosy, there is evidence of hidden cases and an association between higher rates of leprosy detection and greater social vulnerability remain.
- 6 July 2018
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 146 (14) , 1750-1755
Open AccessAssessing epidemiology of leprosy and socio-economic distribution of cases
Leprosy still represents a serious health problem in a number of countries, including Brazil. Although leprosy has been associated with poverty for a long time, it is still difficult to accurately define this relationship. Here, we evaluated in an endemic municipality the progress from 1995 to 2015 of epidemiological indicators to establish if there were any strong associations between social indicators and the occurrence of leprosy. An ecological study was conducted using the SINAN database (Brazilian leprosy-national notifiable diseases information system) in combination with georeferencing of leprosy cases. The georeferencing used the ArcGis programme and occurrence of cases was evaluated in relation to the Health Vulnerability Index (HVI), an indicator that categorises socio-economic and sanitation factors. The data identified a marked decrease in the overall prevalence of leprosy, a reduction in the new case-detection rate and a reduction in the number of cases with grade 2 disabilities (albeit with transient peaks in 2007 and 2015). Logistic regression analysis showed association of detection rates with elevated HVI. Thus, while the epidemiological indicators point to the elimination of leprosy, there is evidence of hidden cases and an association between higher rates of leprosy detection and greater social vulnerability remain.